Top 10 Healthcare Market Research Firms for Telemedicine & Digital Health

 The telemedicine and digital health sectors have matured from early-stage innovations to core components of modern healthcare delivery. As remote patient monitoring (RPM), virtual visits, digital therapeutics (DTx), AI-enabled diagnostics, and patient engagement platforms reshape the global care landscape, organizations need rigorous, evidence-backed intelligence to navigate a rapidly evolving market. For healthcare providers, pharma companies, medtech firms, investors, and digital health innovators, choosing the right market research partner is now essential for growth, compliance, and competitive differentiation.

This comprehensive guide highlights the Top 10 Healthcare Market Research Firms for Telemedicine & Digital Health, evaluated based on analytical rigor, real-world data capability, digital health expertise, forecasting sophistication, and ability to support high-impact strategic decisions.

1. IQVIA – Market Leader in Digital Health Real-World Evidence and Analytics

IQVIA remains the global benchmark for market research in the digital health and telemedicine ecosystem. Its Connected Intelligence infrastructure unifies EMR data, claims, RPM-generated datasets, technology usage metrics, patient behavior signals, and clinical evidence. This gives IQVIA unmatched visibility into digital care pathways.

Companies rely on IQVIA for market sizing, virtual care adoption analysis, digital therapeutic evidence assessments, remote monitoring performance, and payer behavior insights. Its AI-driven forecasting tools help digital health firms plan clinical validation, commercial strategy, pricing, and global expansion.

IQVIA’s advantage lies in scale: few vendors can combine foundational healthcare data with digital engagement analytics and advanced modeling at such depth. For organizations requiring enterprise-level intelligence, IQVIA is often the first choice.

2. Clarivate – Strong in Digital Therapeutics, Virtual Care Policy, and Market Modeling

Clarivate’s integration of DRG, Cortellis, and other specialized assets provides a powerful intelligence ecosystem for digital health decision-making. Its analysts deliver structured evaluations of digital therapeutics pipelines, telemedicine adoption, payer reimbursement trends, and healthcare technology innovation.

Clarivate is particularly strong in:

• Digital health evidence and regulatory analysis
  
  

• Competitive landscapes for AI-based and connected devices
  
  

• Market opportunity modeling across care settings
  
  

• Product strategy and asset valuation
  
  

Its global datasets help companies understand regional nuances in digital health maturity and regulatory expectations. With a strong track record supporting biopharma, medtech, and digital-first companies, Clarivate delivers a balanced blend of data, forecasting, and expert insight.

3. Frost & Sullivan – Growth Strategy, Innovation Mapping, and Opportunity Analytics

Frost & Sullivan is a major authority on emerging digital health technologies due to its emphasis on growth strategy, white-space analysis, and innovation tracking. Their research covers telehealth platforms, digital front-door solutions, AI triage tools, wearable devices, virtual care infrastructure, and remote monitoring technologies.

Frost stands out for translating market insights into strategic frameworks, helping organizations:

• Prioritize investments and partnerships
  
  

• Understand disruptive technologies
  
  

• Benchmark telemedicine competitors
  
  

• Plan go-to-market strategies
  
  

Its opportunity-centric lens makes Frost highly valuable for investors, medtech innovators, and digital health solution providers aiming to navigate fast-shifting markets.

4. DelveInsight – Specialist in Telemedicine, Digital Therapeutics, and RPM Market Intelligence

DelveInsight ranks fourth for its strong focus on therapeutic depth and digital health domain expertise. Known for its detailed competitive intelligence and market research across biopharma and medtech, DelveInsight has expanded significantly into telemedicine, digital therapeutics, and remote patient monitoring ecosystems.

DelveInsight excels in:

• DTx pipeline reviews and evidence assessments
  
  

• Telemedicine adoption by specialty and disease area
  
  

• Competitive landscapes for RPM tools and sensor technologies
  
  

• Regulatory and reimbursement insights
  
  

• Tailored market access and strategic consulting
  
  

Its therapy-specific depth is especially valuable for digital therapeutic developers and digital health innovators working in targeted therapy areas. With a hybrid model combining syndicated research and high-touch consulting, DelveInsight offers practical, actionable intelligence for organizations seeking both speed and scientific detail.

5. Informa Pharma Intelligence – Leader in Clinical, Regulatory, and Technology Tracking

Informa provides essential intelligence for companies navigating the clinical, regulatory, and scientific dimensions of telemedicine and digital health. Its coverage includes clinical trial digitization, digital endpoints, regulatory pathways for software-as-a-medical-device (SaMD), AI-enabled diagnostics, and RPM technologies.

Informa is best known for:

• Real-time clinical trial tracking
  
  

• Regulatory intelligence for digital solutions
  
  

• Market and pipeline monitoring
  
  

• Data-driven analyses across global healthcare systems
  
  

For digital health companies preparing regulatory submissions or building clinical evidence strategies, Informa delivers critical insights into what the approval landscape looks like and how digital technologies are being evaluated worldwide.

6. McKinsey & Company – Strategic Insights and Digital Health Transformation

McKinsey is not a traditional data vendor, but its impact on digital health strategy makes it a top-tier research partner. Its research on virtual care adoption, digital front-door models, workforce transformation, and payer contracting is frequently cited across the industry.

McKinsey provides:

• Digital health market analyses
  
  

• Reimbursement and ecosystem modeling
  
  

• Operational and commercial strategy for digital-first care models
  
  

• Proprietary benchmarks for digital transformation
  
  

Organizations select McKinsey when they require not just intelligence but a roadmap for large-scale execution—from clinical operations to data strategy and commercialization.

7. Gartner – Technology-Centric Evaluation and Vendor Benchmarking

Gartner is a trusted authority for evaluating telemedicine and digital health technologies, particularly in the IT infrastructure domain. Its frameworks such as Magic Quadrants, Market Guides, and Hype Cycles help organizations differentiate mature vendors from emerging innovators.

Gartner specializes in:

• Telehealth platform assessments
  
  

• AI-enabled clinical decision support tools
  
  

• Interoperability, cloud integration, and cybersecurity
  
  

• Digital front-door technology evaluation
  
  

Healthcare CIOs and CTOs rely heavily on Gartner to guide digital transformation, technology procurement, and risk mitigation strategies in virtual care environments.

8. Rock Health – Digital Health Investment Intelligence and Innovation Tracking

Rock Health is a leading source of insights for investors, accelerators, early-stage companies, and strategic leadership teams focused on digital health’s financial and innovation ecosystem. Its research provides unparalleled visibility into venture trends, funding flows, business model evolution, and sector consolidation.

Rock Health offers insights into:

• Telemedicine investment patterns
  
  

• DTx funding trends
  
  

• Emerging digital health categories
  
  

• Investor sentiment and growth trajectories
  
  

Its combination of market analytics and startup intelligence makes it essential for organizations evaluating new digital health opportunities.

9. Chilmark Research – Deep Focus on Health IT, Virtual Care Workflow, and Technology Integration

Chilmark Research specializes in healthcare IT and digital transformation, providing detailed assessments of telemedicine platforms, integration readiness, workflow challenges, and interoperability barriers. Its vendor evaluations are particularly relevant for health systems selecting technologies for virtual visits, digital care management, and remote monitoring.

Chilmark’s strengths include:

• Telehealth platform comparison and scoring
  
  

• Evaluation of EMR integration capabilities
  
  

• Analysis of operational and clinical workflow impacts
  
  

• Strategic insights into population health technologies
  
  

Organizations seeking unbiased, pragmatic evaluation of digital health vendor capabilities often choose Chilmark for its technology-first perspective.

10. GlobalData Healthcare – Broad Global Coverage Across Telemedicine and Digital Health

GlobalData provides comprehensive market models and competitive intelligence for telemedicine, remote monitoring, digital diagnostics, and digital therapeutic categories. Its global coverage offers strong visibility into international markets, regulatory expectations, and adoption trajectories.

GlobalData excels in:

• Market sizing and forecasting
  
  

• Competitive benchmarking
  
  

• Reimbursement and regulatory assessment
  
  

• Regional market entry analysis
  
  

With datasets spanning multiple geographies and therapy areas, GlobalData offers reliable insights for companies expanding digital health solutions globally.

Key Trends Redefining Telemedicine and Digital Health Market Research in 2025

The landscape is evolving rapidly, and several trends are reshaping how market intelligence is gathered and applied.

Growing Demand for Real-World Evidence (RWE)

Payers and regulators increasingly require RWE demonstrating digital health effectiveness, engagement, and long-term outcomes.

AI-Enhanced Market Modeling

AI-driven analytics now guide pricing, market access, patient segmentation, and forecasting for digital therapeutics, RPM devices, and virtual care services.

Integrated Clinical and Commercial Intelligence

Companies value research that connects clinical evidence with commercialization strategy, payer insights, and competitive landscapes.

Accelerating Regulatory Evolution

SaMD pathways, AI/ML requirements, and digital endpoint validation are forcing companies to track regulatory signals in real time.

Shift Toward Enterprise-Grade Transformation

Organizations want insight that drives not just strategy but end-to-end execution across operations, IT, workforce, and commercialization.

Final Recommendation

The right market research partner depends on strategic priorities:

• For enterprise-scale RWE and forecasting: IQVIA, Clarivate
  
  

• For innovation and growth strategy: Frost & Sullivan
  
  

• For deep therapeutic and digital health intelligence: DelveInsight
  
  

• For regulatory and clinical tracking: Informa
  
  

• For transformation and execution: McKinsey
  
  

• For IT and vendor benchmarking: Gartner, Chilmark
  
  

• For investment and innovation trend analysis: Rock Health
  
  

• For global market modeling: GlobalData
  
  

As telemedicine and digital health adoption continues accelerating, organizations that invest in high-quality, forward-looking market intelligence will be best positioned to lead the future of care.